Oxidative stress in patients with type 2 diabetes mellitus treated with metformin

Abstract

AIMS: To evaluate oxidative stress parameters in patients with type 2 diabetes mellitus treated with metformin, relating these values to its side effects, plasma levels, glycemic control, diabetic complications, lipid profile, and the influence of pharmacotherapeutic follow-up. METHODS: Patients with type 2 diabetes mellitus, on metformin and in pharmacotherapeutic follow-up for four months, were evaluated. The pharmacotherapeutic follow-up consisted in providing information and answering patients' questions about medication and disease. In addition, administration times, dosages, and presence or absence of side effects related to the use of metformin were verified. Glycemic and lipid profile, oxidative stress (superoxide dismutase and malondialdehyde) and plasma metformin were evaluated. Pearson's correlation and Spearman's correlation were performed to evaluate the relationship between the variables at the beginning of the study. The independent t-test and Mann-Whitney U test were used to assess the difference between the groups with and without diabetic complications. The range of values between the beginning and end of the study was evaluated using Student's t-test or Wilcoxon U test. The significance level was set at 5%. RESULTS: The initial sample consisted of 49 patients aged 59±9 years with a body mass index of 29.8±5.1 kg/m 2 , who have had diabetes for a median time of 36 months (interquartile range of 1-240) and have been on metformin for a median time of 36 months (interquartile range of 1-180). Twenty-five patients left the study between the second and fourth meetings. Malondialdehyde levels differed between before and after pharmacotherapeutic follow-up, being positively correlated with blood glucose, glycohemoglobin, and triglyceride level, and negatively correlated with metformin and superoxide dismutase. Blood glucose, glycohemoglobin, and malondialdehyde levels increased, whereas metformin levels decreased in the group with diabetic complications, and there was a correlation between malondialdehyde and the number of diabetic complications per patient. CONCLUSIONS: In this sample of patients with type 2 diabetes mellitus treated with metformin, oxidative stress was more pronounced in those with poor glycemic control and diabetic complications.KEY WORDS: diabetes mellitus; oxidative stress; superoxide dismutase; malondialdehyde; metformin; diabetic complications. RESUMOOBJETIVOS: Avaliar parâmetros de estresse oxidativo em pacientes com diabetes mellitus tipo 2 em uso de metformina, relacionando estes valores a seus efeitos adversos, níveis plasmáticos, controle glicêmico, complicações diabéticas, perfil lipídico, e a influência do acompanhamento farmacoterapêutico. MÉTODOS: Foram avaliados pacientes com diabetes mellitus tipo 2, em uso de metformina, em acompanhamento farmacoterapêutico por quatro meses. O acompanhamento farmacoterapêutico consistiu na prestação de informações e no esclarecimento de dúvidas dos pacientes sobre a medicação e a doença. Além disto, foram verificados os horá...

Effect of Type-2 Diabetes Mellitus in Retinopathy Patients on MDA, SOD Activity and its Correlation with HbA1c

“…The HbA1c% shows the negatively correlated to superoxide dismutase (SOD) but positively correlated to malondialdehyde (MDA) but it was not significant. Other authors also reported same thing as our study shows the positive correlation between glycemic control parameters and MDA in DM patients [17,18,29,30] due to excessive accumulation of lipid peroxidation products. Our study revealed that SOD activity was decreased as in case of T-2DM with complication than without complication and control group due to auto-oxidation of glucose and more H2O2 production, but it was reverse in other reported studies due to increased protein glycation, which leads to reduced vascular concentrations of SOD-3 in relation to intracellular SOD-1 activity is also decreased, resulting into an increased superoxide production [22,31,32].…”

Oxidative Stress and Cytokines’ Involvement in the Occurence and Progression of Diabetic Complications in the Covid-19 Pandemic Context

“…Another protective role is to reduce the concentration of insulin, thus diminishing the hyperinsulinism associated stress [19,53]. In patients with poor glycaemic control and diabetic complications, with documented high OS levels, metformin could prevent further development of complications [17,60,83]. Liraglutide is a glucagon like peptide-1 receptor agonist that improves glucose-dependent insulin secretion capacity and beta-cell function [77].…”

Effect of Supplementation of Acacia Honey and Pioglitazone on Blood Glucose Levels in Streptozotocin-Induced Type 2 Diabetic Rats

“…1 The management of DM involves pharmacological (use of oral hypoglycemic drugs and/or insulin) and non-pharmacological approaches. 2 The oral hypoglycemic drugs include Sulfonylureas, Biguanides and Thiazolidinediones. The Thiazolidinediones like Pioglitazone are selective ligands for peroxisome proliferator-activated receptors (PPAR-γ).…”